Mohamed Sikkander Abdul Razak/LinkedIn
Apr 6, 2026, 10:03
Mohamed Sikkander Abdul Razak: Clinical Steps for Evaluating and Managing Heavy Menstrual Bleeding
Mohamed Sikkander Abdul Razak, Professor at GKM College of Engineering Technology, shared a post on LinkedIn:
“Clinical steps for evaluating and managing heavy menstrual bleeding (HMB):
1. Initial assessment:
- Detailed history (menstrual pattern, bleeding severity, iron deficiency, family history of bleeding disorders).
- Physical exam to rule out structural causes (e.g., fibroids).
2.Laboratory evaluation:
- Complete blood count (CBC) to check for anemia.
- Iron studies (serum ferritin, iron levels).
- Coagulation screening: PT, aPTT, von Willebrand factor (vWF) antigen/activity, platelet function tests.
3. Identify underlying hemostatic defect:
- Confirm vWD or platelet dysfunction (most common causes).
- Assess for factor deficiencies if indicated.
4.Management strategies:
Medical therapy:
- Hormonal treatments (combined oral contraceptives, levonorgestrel IUS) to regulate cycles and reduce bleeding.
- Antifibrinolytics (tranexamic acid) during menses to stabilize clots.
Hemostatic therapy:
- vWF concentrates or DDAVP for vWD.
- Platelet transfusions or specific factor replacement if needed.
Surgical options:
- Endometrial ablation or hysterectomy in refractory cases.
5. Pregnancy planning:
- Preconception counseling and hemostatic optimization to prevent miscarriage or postpartum hemorrhage.
- Specialist referral for individualized risk assessment.
6.Follow‑up:
- Monitor hemoglobin and iron levels.
- Re‑evaluate hemostatic workup if bleeding persists or complications arise.”

Find more posts featuring Mohamed Sikkander Abdul Razak on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?